Advantage Health Solutions was placed under the supervision of the Indiana Department of Insurance on Friday after the company lost $46.3 million during the first eight months of the year and decided to terminate its Medicare Advantage business.
Carmel-based Mainstreet has engineered a $302.5 million reverse takeover of a Canadian long-term care company that will once again give Mainstreet a publicly traded investment firm to help finance its development projects.
Hospitals have long argued that they pass on the cost of the uninsured to private insurance customers. But a new study shows that’s less than half-true.
The Indianapolis-based hospital system said its efforts to reduce patients’ need for expensive health care services, known as population health, slashed the use of hospitals, nursing homes and expensive imaging scans among the 140,000 Hoosiers IU Health now serves.
The 130,000-square-foot building will be designed to encourage collaboration among scientists across different disciplines, which the company said is crucial to fostering innovation.
Companies—including Indiana-based OrthoPediatrics Corp.—are starting to answer parents’ call for more help for children.
Lower wages, higher hospital prices and unhealthy lives force Indiana employers to charge more and give fewer health benefits to their workers.
The prices health insurers charge Hoosiers on the Obamacare exchange will drop more than in any other state next year. But for most Hoosiers, that’s bad news. Lower average premiums statewide means smaller tax subsidies statewide to reduce the cost of Obamacare policies.
Slipping enrollment has done little to shake the faith that the nation's biggest health insurers, including Anthem, have placed in the Affordable Care Act's public insurance exchanges.
City leaders want to make the 60-acre tract of land just north of the Indiana University School of Medicine campus a mix of all of the best the city has to offer and catch the eyes of more creative and highly sought-after workers.
A subsidiary of Zimmer Biomet Inc. in Warsaw will argue that it should not have to pay about $248 million in a patent infringement case.
Researchers at the Indiana University School of Medicine found that blocking the activity of a key protein can significantly cut down on the graft-versus-host immune response suffered by large numbers of patients who receive stem cell transplants.
Jeff Simmons is on a counteroffensive as, increasingly, the drugs that Elanco makes—including antibiotics and productivity enhancers—have come under attack by food activists.
Adjusted earnings of 34 cents per share missed the expectations of analysts who follow the Carmel-based insurance holding company.
Shares in Anthem Inc., the nation's third-largest health insurer by market value, dropped Wednesday after the company’s 2015 profit outlook fell short of estimates.
Anthem’s third-quarter profit rose nearly 4 percent as it added 174,000 health plan members. Its Medicaid, local employer and national employer segments all grew, although its individual business saw losses.
Former Eli Lilly and Co. CEO Sidney Taurel has been named chairman of Pearson PLC, the London-based media and educational products giant announced Monday.
Eli Lilly and Co. CEO John Lechleiter told Wall Street analysts recently that, while there have been “individual huge drug price increases,” the overall cost of drugs is rising very slowly and remains a small part of overall U.S. health care spending.
Sandra is the daughter of Sidney and Lois Eskenazi, the couple who provided a $40 million gift to the Eskenazi Health Capital Campaign and for whom the Eskenazi Health system is named.
A Census Bureau survey suggests that medical device firms created 20,000 fewer jobs from 2011 to 2013 than they should have—and some of those missing jobs probably can be blamed on Obamacare’s medical device tax.
